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Abstract
Background: Feline leukemia virus (FeLV) is an exogenous gammaretrovirus of domestic cats (Felis catus) and some
wild felids. The outcomes of FeLV infection in domestic cats vary according to host susceptibility, virus strain, and
infectious challenge dose. Jaguarundis (Puma yagouaroundi) are small wild felids from South and Central America.
We previously reported on FeLV infections in jaguarundis. We hypothesized here that the outcomes of FeLV infection
in P. yagouaroundi mimic those observed in domestic cats. The aim of this study was to investigate the population of
jaguarundis at Fundação Parque Zoológico de São Paulo for natural FeLV infection and resulting outcomes.
Methods: We investigated the jaguarundis using serological and molecular methods and monitored them for FeLV-related
diseases for 5 years. We retrieved relevant biological and clinical information for the entire population of 23 jaguarundis held
at zoo. Post-mortem findings from necropsies were recorded and histopathological and immunohistopathological analyses
were performed. Sequencing and phylogenetic analyses were performed for FeLV-positive samples. For sample prevalence,
95% confidence intervals (CI) were calculated. Fisher’s exact test was used to compare frequencies between infected and
uninfected animals. P-values <0.05 were considered significant.
Results: In total, we detected evidence of FeLV exposure in four out of 23 animals (17%; 95% CI 5–39%). No endogenous
FeLV (enFeLV) sequences were detected. An intestinal B-cell lymphoma in one jaguarundi was not associated with FeLV.
Two jaguarundis presented FeLV test results consistent with an abortive FeLV infection with seroconversion, and two
other jaguarundis had results consistent with a progressive infection and potentially FeLV-associated clinical disorders
and post-mortem changes. Phylogenetic analysis of env revealed the presence of FeLV-A, a common origin of the virus
in both animals (100% identity) and the closest similarity to FeLV-FAIDS and FeLV-3281 (98.4% identity), originally
isolated from cats in the USA.
Conclusions: We found evidence of progressive and abortive FeLV infection outcomes in jaguarundis, and domestic
cats were probably the source of infection in these jaguarundis.
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Background
Jaguarundis (Puma yagouaroundi) are small diurnal fe-
lids that have several unpatterned color morphs –
brownish-black, gray and reddish-yellow fur – and are
protected across most of their range. The species occurs
at low densities and has a decreasing population in the
wild, despite being widely distributed throughout South
and Central America and occupying a broad range of
habitats [1]. Mainly due to displacement from nature
and, to a lesser extent, to captive breeding, jaguarundis
are commonly found in zoos and similar captive settings
in Brazil [2].
The feline leukemia virus (FeLV) is an exogenous,
oncogenic, immunosuppressive gammaretrovirus that
can establish persistent infections in domestic cats (Felis
catus) [3]. The prevalence of FeLV ranges from 1% to 8%
in healthy cats almost everywhere in the world and is
usually higher when sick cats are included [4]. FeLV is
naturally transmitted by oronasal exposure to virus-
containing secretions, mainly saliva, but also in feces
and urine [5–7]. The effects of FeLV are cytoproliferative
diseases including lymphomas and myeloproliferative
disorders; degenerative illnesses, such as anemia and
leukopenia; and immunosuppressive diseases associated
with opportunistic infections [3, 8].
FeLV infections tend to be rare or absent in many
nondomestic felid species [9–14], except for the Euro-
pean wildcat (Felis silvestris silvestris), a species very
closely related to the domestic cat, in which FeLV ap-
pears to be endemic [15–17]. However, documentation
of FeLV is becoming more common in wild felid species
less closely related to the genus Felis, which highlights
the omnipresent threat that FeLV represents to the con-
servation of wild felids worldwide. FeLV has been shown
to represent a major threat to the survival of critically
endangered populations of Iberian lynxes (Lynx pardi-
nus) in Europe [18, 19] and to Florida panthers (Puma
concolor coryi) in North America [20, 21]. In Brazil, anti-
bodies against FeLV have been detected in two free-
ranging pumas (Puma concolor) and two jaguarundis;
FeLV DNA was detected in the following captive felids:
an ocelot (Leopardus pardalis), an oncilla (Leopardus
tigrinus) and two jaguarundis [22–24].
For domestic cats, the detection of the structural viral
protein FeLV p27 in serum or plasma is used as a
marker of infection and, in most cases, as a parameter
for viremia. The outcomes of FeLV infection vary ac-
cording to infectious challenge dose, route of challenge,
and possibly host susceptibility and virus strain. The
classification of FeLV outcomes in the domestic cat has
been refined using sensitive molecular assays that detect
and quantify proviral FeLV DNA and viral FeLV RNA, in
addition to traditional serological and virological
methods [25–30]. In this regard, the main host response
categories of FeLV infection in domestic cats have been
redefined as abortive, regressive, and progressive infec-
tion. In short, those cats that abort infection do not
show any evidence of virus infection, except for serocon-
version. Cats with regressive infection overcome viremia
after an undetectable or transient initial phase by means
of efficient cellular and humoral immune responses.
These cats seroconvert, permanently harbor low to mod-
erate FeLV proviral loads integrated in mononuclear
cells, i.e., lymphocytes, and may or may not clear their
plasma viral RNA loads [25, 27, 31]. Cats with progres-
sive infection are constantly viremic, have low or no
antibodies to FeLV, show elevated FeLV proviral and
viral loads in peripheral blood cells and plasma and may
develop FeLV-associated disease [25, 26, 28, 29].
In previous surveillance work, we detected FeLV infec-
tion in two captive-born jaguarundis (#1 and #4) as well
as previous exposure to FeLV in two other captive-born
jaguarundis (#2 and #22) among a population of 23 jag-
uarundis held at Fundação Parque Zoológico de São
Paulo (FPZSP), Brazil [23]. Jaguarundis #1 and #4 tested
positive for FeLV p27 antigen by sandwich ELISA. FeLV
proviral DNA was detected in blood from both animals
by quantitative real-time polymerase chain reaction
(qPCR). The sampling for this previous study occurred
between 2003 and 2004 (Table 1).
By analogy, we hypothesized here that FeLV infection
in P. yagouaroundi mimics the main outcomes observed
for the domestic cat. Thus, the aim of this study was to
perform additional serological and molecular tests and
monitor the population of jaguarundis at FPZSP for
FeLV infection and development of FeLV-related dis-
eases for 5 years (2003–2007).
Methods
Animals and sample collections
We retrieved relevant biological and clinical information
for the entire population of 23 jaguarundis held at
FPZSP, from birth or admission of the animals into the
zoo until 2007. Most animals were mature adults (n =
16), five were immature and two were geriatric; kittens
were absent. Three jaguarundis were wild born, while 20
were captive born at FPZSP. Six females (two of wild
origin) and three zoo-born males were reproductively
active. Eleven animals from the population were full sib-
lings, and 16 were half siblings. The females (n = 9) aver-
aged 4.28 ± 0.57 kg in body weight, and the males (n =
14) averaged 5.08 ± 0.49 kg in body weight. Detailed bio-
logical data such as age, sex, weight, origin (captive or
wild born) and the parental history for the 23 jagua-
rundis are presented in Table 2.
For hematological analysis, several laboratories were
used over time, and registries of results from the animals
were not completed and standardized. All jaguarundis
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Table 2 Biological data of the studied population of 23 jaguarundis (Puma yagouaroundi)
Animal CAD Sex Weight (kg) Origin Sampling date Date of birth
/zoo entrancea
Age in months Age groupb Father
(CAD)
Mother
(CAD)
#1 20761 male 5.130 captive
born
23/06/2004 24/06/1993 132 geriatric 19914 15245
#2 20762 female 4.505 captive
born
26/11/2003 24/06/1993 125 geriatric 19914 15245
#3 21566 female 4.835 wild
born
10/12/2003 01/05/1994a 115 mature
adult
wild born wild
born
#4 21810 male 3.985 captive
born
23/06/2004 27/12/1994 114 mature
adult
wild born wild
born
#5 22096 male 5.165 captive
born
23/06/2004 17/08/1995 106 mature
adult
19914 15245
#6 23120 female 5.320 captive
born
26/11/2003 09/03/1997 80 mature
adult
17406 22097
#7 23851 female 4.250 captive
born
03/12/2003 20/06/1998 66 mature
adult
17406 20762
#8 23911 male 5.505 captive
born
10/12/2003 15/08/1998 64 mature
adult
unknownc 18544
#9 23956 male 5.260 captive
born
10/12/2003 14/09/1998 63 mature
adult
17406 unknownc
#10 24142 female 4.315 wild
born
26/11/2003 01/12/1998a 59 mature
adult
wild born wild
born
#11 24189 male 5.925 captive
born
26/05/2004 05/01/1999 64 mature
adult
19914 23120
#12 24226 male 4.925 captive
born
25/05/2004 16/02/1999 63 mature
adult
19914 21566
#13 24227 male 4.920 captive
born
03/12/2003 16/02/1999 58 mature
adult
19914 21566
#14 24958 male 5.300 captive
born
30/06/2004 02/03/2000 51 mature
adult
23119 21566
#15 25244 female 3.685 captive
born
26/11/2003 05/11/2000 36 mature
adult
23956 24142
#16 25845 male 5.665 captive
born
26/05/2004 06/04/2001 37 mature
adult
22096 23851
#17 25846 male 4.490 captive
born
26/05/2004 06/04/2001 37 mature
adult
22096 23851
#18 26005 female 4.105 wild
born
19/11/2003 12/06/2001a 29 mature
adult
wild born wild
born
#19 27088 male 4.765 captive
born
03/12/2003 07/01/2002 23 immature
adult
23119 25244
#20 27155 male 4.755 captive
born
10/12/2003 20/02/2002 22 immature
adult
23956 24142
#21 27156 female 4.090 captive
born
26/11/2003 20/02/2002 21 immature
adult
23956 24142
#22 27689 male 5.325 captive
born
03/12/2003 01/09/2002 15 immature
adult
22096 23851
#23 28018 female 3.410 captive
born
19/11/2003 15/03/2003 8 immature
adult
21810 20762
Notes: FeLV-infected (#1, #4) and FeLV seropositive (#2, #22) jaguarundis are identified in bold. aFor the wild-born jaguarundis (#3, #10 and #18), the dates refer to
entrance in the zoo as their dates of birth are unknown. bImmature adults (n = 5) were defined as jaguarundis in the age range of 6 months ≤ age < 24 months
for males and 6 months ≤ age < 36 months for females; mature adults (n = 16) were defined as those in the age range of 24 months ≤ age < 10 years (120 months)
for males and 36 months ≤ age < 10 years for females; geriatric jaguarundis (n = 2) were those aged ≥10 years for both sexes. cFor two captive-born jaguarundis
(#8, #9), the identities of the father and the mother, respectively, were not available
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were vaccinated regularly against feline herpesvirus 1
(FHV-1), feline calicivirus (FCV), feline parvovirus (FPV)
and rabies lyssavirus. We monitored the potential devel-
opment of FeLV-related diseases through clinical data
provided by the veterinarian staff at the zoo and regis-
tered at the zoo archives.
Serological and molecular FeLV tests were performed,
in addition to those previously published [23], using
samples that had been previously obtained or additional
samples collected throughout the observation period.
FeLV tests previously performed included p27 FeLV anti-
gen detection by a sandwich ELISA and the commercial
immunoassay Snap™ Combo FeLV Antigen/FIV Antibody
Test Kit (IDEXX Laboratories Inc., Westbrook, ME,
USA), detection of antibodies against the recombinant
non-glycosylated form of the FeLV gp70 surface glyco-
protein (p45) by indirect ELISA, detection of antibodies
against FeLV p12, p15, p27, p58, and gp70 antigens by
Western blot and detection of FeLV proviral DNA by
real-time PCR. We investigated the presence of anti-
bodies to FeLV transmembrane protein p15E in serum
samples from six jaguarundis (#1, #3, #4, #5, #14 and
#17) using the previously described assay [32, 33].
Six jaguarundis (#1, #2, #4, #5, #10 and #14) died
between 2005 and 2008 and underwent necropsy at the
zoo; for these jaguarundis, relevant clinical and post-mor-
tem findings from necropsies were recorded, and several
tissues were collected for analyses. Fragments of tissues
from these animals were fixed in 10% formalin, embedded
in paraffin wax and sectioned. The sections were stained
with hematoxylin-eosin (HE) on glass slides for histopatho-
logical analyses. Tissue specimens from animals #1 and #5
(bone marrow, mesenteric lymph node and spleen) were
also stored at ≤ −70 °C. A saliva specimen from animal #1
was collected at first sampling using a sterile cotton swab
immersed in virus transport media, which consisted of
phosphate-buffered saline (PBS) balanced salt solution sup-
plemented with 0.5% bovine albumin (BSA), antimicrobial
agents (200 U/mL penicillin G, 200 U/mL streptomycin,
25 μg/mL fungizone and 6 μg/mL gentamycin) and was
kept at ≤ −70 °C. No additional material could be obtained
from animal #2.
Immunohistology
To clarify the histogenesis of an intra-abdominal mass
of tissue that developed in jaguarundi #5, we performed
immunohistologic assays by the streptavidin-biotin-
peroxidase complex technique with a commercial
immunoperoxidase kit (LSAB kit, Dako, Glostrup,
Denmark) according to the manufacturer’s protocol.
We used silanized microscope slides to produce histo-
logic slides, which were processed by usual deparaffina-
tion techniques in xylol and hydrated in alcohols
(absolute, 95%, 70%, and distilled water). A microwave
antigen retrieval technique using EDTA buffer, pH 9.0,
was applied [34]. The sections were incubated over-
night at 4 °C with primary antibodies against the T-cell
marker CD3 (rabbit polyclonal antibodies A0452; Dako;
diluted 1 in 500), the B-cell marker CD79 (mouse
monoclonal antibodies; clone HM57; M7051; Dako;
diluted 1 in 500), and vimentin (mouse monoclonal
antibodies; M0725; Dako; diluted 1 in 100) as well as
antibodies against proliferating cell nuclear antigen anti-
bodies (PCNA) (mouse monoclonal antibodies; M0879;
Dako; diluted 1 in 800). For all reagents, negative controls
were generated by substituting the primary antibody with a
class-matched immunoglobulin. These procedures were con-
ducted using the logistics of the Department of Pathology,
School of Veterinary Medicine and Animal Sciences, Univer-
sity of São Paulo (USP), São Paulo, SP, Brazil.
We investigated the presence of FeLV antigens in sev-
eral paraffin-embedded tissues from the deceased jagua-
rundis #1, #4, #5 and #14. This investigation was carried
out using the methods and logistics of the Institute of
Veterinary Pathology, University of Giessen, Giessen,
Germany [35].
Extraction of nucleic acids
Total nucleic acid (TNA) was extracted from 100 μL of
EDTA-anticoagulated whole blood or buffy coat or from
200 μL of EDTA-anticoagulated plasma using the
MagNA Pure LC Total Nucleic Acid Isolation Kit
(Roche Diagnostics, Rotkreuz, Switzerland). TNA was
eluted into 100 μL of elution buffer and stored at −70 °C
until PCR testing was performed. RNA was extracted
from the saliva, plasma samples collected from jaguar-
undi #1 and from serum samples from jaguarundis #1
and #4 using the QIAmp® Viral RNA Mini Kit (Qiagen).
gDNA and RNA were extracted from tissues (bone mar-
row, mesenteric lymph node and spleen) from animals
#1 and #5 upon necropsy, as previously described [36,
37]. During all extractions, negative controls consisting
of 100 μL of PBS were concurrently prepared with each
batch of samples to monitor for cross-contamination.
Molecular tests for FeLV
FeLV viral RNA loads and proviral loads were investigated
using real-time RT-PCR and PCR and primers targeting the
U3 region of exogenous FeLV, as previously described [30].
For tissue samples, the total copy numbers detected per re-
action were normalized to the glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) gene as described [38].
FeLV subgroups A, B and C were investigated in the bone
marrow, mesenteric lymph node, and spleen of the jaguar-
undi #1 and in the serum and plasma of jaguarundi #4 by
conventional PCR using the FeLV-A specific primers RB59
and RB17; the FeLV-B specific primers RB53 and RB17 and
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the FeLV-C specific primers RB58 and RB47 as described
[39, 40].
Feline immunodeficiency virus (FIV) serology and
molecular assays
Serum from jaguarundi #5 was tested for the presence of
antibodies against feline immunodeficiency virus (FIV)
using a commercial immunoassay Snap™ Combo FeLV
Antigen/FIV Antibody Test Kit (IDEXX Laboratories) and
by Western blotting, as described [41]. FIV real-time and
conventional RT-PCR were performed from whole blood
from jaguarundi #5, as previously described [42, 43].
Endogenous FeLV-like sequences (enFeLV) PCR
TNA samples from the whole blood or buffy coat of all 23
jaguarundis were tested for the presence of endogenous
FeLV (enFeLV) by the three qPCR assays enFeLV-U3–1,
enFeLV-U3–2, and enFeLV-env, as previously described [44].
Sequencing of FeLV env from jaguarundis #1 and #4
FeLV env sequences were analyzed for the FeLV-positive
jaguarundis #1 and #4 from TNA of previously collected
buffy coats. For comparison, a second sequence obtained
from bone marrow of animal #1 was analyzed 1.4 years
later, at the time of euthanasia. For the analysis of the
full-length FeLV env sequences, genomic DNA from
these samples was amplified using PCR with the primers
5847F (5′ ACATATCGTCCTCCTGACCAC 3′) and
8197R (5′ GAAGGTCGAACCCTGGTCAACT 3′) [43],
yielding an approximately 2´370 bp product. To ensure
high-fidelity amplification, the PCR was performed using
Phusion polymerase and HF buffer (Finnzyme, Ipswich, UK).
PCR products were sequenced by Microsynth (Balgach,
Switzerland) after purification using the GenElute PCR
Clean-Up Kit (Sigma, Fluka GmbH, Buchs, Switzerland).
The jaguarundi FeLV-A env sequence was submitted to
GenBank [KR349469].
Phylogenetic analysis
Phylogenetic analyses were conducted using MEGA
version 6 [45]. The FeLV env sequences were aligned
using CLUSTAL W [46]. Bootstrap support (1000 repli-
cates) was calculated by the neighbor-joining (NJ) [47]
and maximum parsimony (MP) [48] methods, and re-
sults >70% were considered significant [49]. The MP tree
was obtained using the subtree-pruning-regrafting (SPR)
algorithm [48] with search level 1 in which the initial
trees were obtained by the random addition of
sequences (10 replicates). All positions containing gaps
and missing data were eliminated from the dataset
(complete deletion option).
Statistics
For sample prevalence, 95% confidence intervals (CI)
were calculated. Fisher’s exact test was used to compare
frequencies between infected and uninfected animals. P-
values <0.05 were considered significant.
Results
Clinical data of all 23 jaguarundis
The population of jaguarundis kept at FPZSP from 2003 to
2007 consisted of 23 captive jaguarundis. The animals pre-
sented good general condition at sampling. Twenty animals
presented discrete to moderate oral disorders, including
one or more of the following conditions: gingivitis, presence
of tartar, periodontitis, tooth loss and/or fractured teeth.
No oral disorders were registered in three immature adults,
#19, #21 and #23. At least once during the experiment, 15
animals presented episodes of diarrhea, 11 jaguarundis
demonstrated transitory weight loss and three suffered
from dermatological disorders, such as alopecia; for all
these clinical conditions, the underlying causes of the prob-
lems were unknown. Despite regular deworming, intestinal
parasites were detected in 18 animals during the study
period. In hematological analysis, most animals (n = 16)
showed some degree of leukopenia (marked: n = 1; mild: n
= 8) and leukocytosis (marked: n = 2; mild: n = 5). Jaguar-
undi #1, which was FeLV positive, and jaguarundi #2, which
was FeLV seropositive, showed mild transient leukocytosis.
Several (n = 12) animals showed mildly increased packed
cell volume (PCV) and two showed markedly increased
PCV in at least one sampling. Jaguarundis #1 and #2
showed mildly increased PCV, and jaguarundi #22, which
was FeLV seropositive, showed a markedly increased PCV.
The increased PCV could be due to dehydration as the
animals had been fasted before immobilization.
Deceased animals
Six jaguarundis (#1, #2, #4, #5, #10 and #14) in the
investigated population died from 2005 to 2008. Jag-
uarundi #1 was euthanized 1.4 years after being diag-
nosed with FeLV infection [23]. This jaguarundi was
euthanized because the zoo could not keep it segre-
gated under good ethological conditions, although the
animal was in good clinical condition. Jaguarundi #5
developed a large intra-abdominal mass of tissue
about 1 year after testing negative for FeLV. After clin-
ical and ultrasonographic examinations, the animal
underwent laparotomy for excision of the mass and
died 3 days after surgery due to clinical deterioration.
Animals #2, #4, #10 and #14 died naturally during the
period of study. For the six deceased animals, clinical
conditions and main post-mortem findings are pre-
sented in Table 3.
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Indirect ELISA for p15E
Antibodies against p15E antigen were not detected to a
level that is considered positive for privately owned do-
mestic cats and the results from all the jaguarundis
tested (#1, #3, #4, #5, #14 and #17) were negative
(Table 1).
FeLV-negative B-cell lymphoma in jaguarundi #5
The excised mass of tissue from jaguarundi #5 weighed
approximately 0.25 kg and affected all layers of the wall of
the jejunum. In addition, several small foci were present
across the mesentery. There was multifocal necrosis as well
as intense reactional fibrosis and proliferation of round cells
arranged in dense blocks limited by delicate conjunctive
septa. The cells were neoplastic and malignant and
presented anisokaryosis, anisocytosis, and a high mitotic
index. The tumor was found to be an intestinal B-cell
lymphoma, as the cells stained positive for a B-cell marker
(CD79) but not a T-cell marker (CD3) by immunohistology.
No FeLV RNA or provirus was detected in the tissues
collected upon necropsy, including tumoral tissues, bone
marrow, mesenteric lymph nodes and spleen, and no FeLV
antigens were detected in paraffin-embedded tissues by
immunohistological analysis (Table 1). Because B-cell
lymphomas can also be associated with FIV infection, jag-
uarundi #5 was tested for FIV by serology and PCR. The
animal tested negative for antibodies to FIV in the commer-
cial assay. In the FIV Western blot, one band against p24
was detectable.
Molecular detection of FeLV-A in two jaguarundis (#1
and #4)
FeLV RNA and proviral DNA were detected in two
out of the 23 animals, namely, jaguarundis #1 and #
4. From jaguarundi #1, a saliva sample was available;
it was FeLV RNA positive, indicating shedding of
FeLV at the time of sampling. FeLV was also demon-
strated in the plasma sample collected at a second
sampling from jaguarundi #4 upon necropsy 1.4 years
later, indicating persistent antigenemia in this ani-
mal. For jaguarundis #1 and # 4, respectively, the
absolute copy numbers of proviral DNA were 4.26 ×
107 and 3.49 × 107 copies of DNA/mL of buffy coat;
the absolute copy numbers of viral RNA were 2.63 ×
108 and 2.97 × 109 copies of RNA/mL of serum. The
results from all FeLV tests are presented in Tables 1
and 4. Furthermore, FeLV could be demonstrated in
the tissue samples collected at necropsy from jaguar-
undi #1, and FeLV antigens were confirmed by
immunohistological analysis of paraffin-embedded
tissue samples from deceased jaguarundis #1 and #4.
For both jaguarundis, #1 and #4, FeLV-A was the
only FeLV subtype identified; no FeLV-B or FeLV-C
was detected.
No detection of enFeLV
No enFeLV was detected in the blood or buffy coat samples
from any of the 23 jaguarundis.
Table 3 Clinical and necroscopic findings of five jaguarundis (Puma yagouaroundi) that died between 2005 and 2008
Animal
identification
Origin Sex Age category
at death
Clinical condition
before death
Main post-mortem findings
#1 Captive
born
Male Geriatric Clinically
healthya
Hepatitis, pulmonary edema and emphysema, splenic
lymphoid depletion, renal tubular degeneration, renal
medullary fibrosis, glomerulonephritis, obesity, muscular
atrophy of hind limbs
#2 Captive
born
Female Geriatric Weight loss Severe membranous proliferative glomerulonephritis,
parasitic hemorrhagic enteritis, hepatic steatosis,
cardiomyopathy
#4 Captive
born
Male Mature Weight loss,
vomiting,
anorexia,
diarrhea
Hepatitis, pulmonary infarction, splenic hypoplasia,
decreased number and size of spleen germinal centers,
membranous proliferative glomerulonephritis, enteritis,
adrenal necrosis
#5 Captive
born
Male Mature Malignant
lymphoma,
weight loss
and clinical
deterioration
Hepatitis, pulmonary emphysema, splenic lymphoid
depletion and follicular hypoplasia, membranous
proliferative glomerulonephritis, renal tubular
degeneration, severe enteritis, malignant neoplasia
of round cells (intestinal B-cell lymphoma)
#10 Wild Female Mature Weight loss,
circulatory
shock,
convulsion
Severe interstitial histiocytic bronchopneumonia
associated with the presence of intralesional protozoa;
intense multifocal and coalescent pancreatic fibrosis
#14 Captive
born
Male Mature Weight loss,
diarrhea
Colitis, enteritis, gastritis, lymphopathy, inguinal
herniation, ulcers on the tongue
aJaguarundi #1 was recognized to be FeLV positive and shedding FeLV in its saliva; thus, the animal was euthanized while clinically healthy to prevent further
spreading of FeLV infection
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Sequencing and phylogenetic analysis of the jaguarundi
FeLV-A
Sequencing of the FeLV isolate retrieved from jaguarundis
#1 and #4 revealed one conserved env sequence with
100% identity. Similarly, no sequence variation could be
detected between the virus present in buffy coat from
jaguarundi #1 and the virus detected in bone marrow at
the time of euthanasia 1.4 years later in the same animal
(100% identity). Phylogenetic analysis conducted by the
MP and NJ methods revealed clustering of the jaguarundi
env with several North American virus strains showing
the closest similarity to FeLV-FAIDS [M18247] and FeLV-
3281 [L25631], with 98.4% identity (Fig. 1). When the env
surface unit from the FeLV detected in jaguarundis was
compared with those found in Iberian lynxes [EU293175
to EU293194], a sequence identity of approximately 97%
was obtained (data not shown).
Discussion
We detected evidence of FeLV exposure in four (#1, #2, #4
and #22) out of 23 jaguarundis in the FPZSP (17%; 95% CI
5–39%). The remaining 19 jaguarundis were negative for
FeLV in all serological and molecular tests performed. The
population of jaguarundis presented clinical disorders that
were common at FPZSP, as in any other captive setting in
Brazil [2, 12], and could be associated with a multitude of
causes. Although the FeLV-positive jaguarundis also
presented some conditions that could be related to FeLV
[8], our data were insufficient to prove a causal association.
Two captive-born male jaguarundis, the geriatric #1 and
the mature adult #4, presented serological and molecular
FeLV test results similar to the progressive FeLV infection
outcome in domestic cats [25]. Jaguarundis #1 and #4 were
both antigenemic. Antigenemia is usually used as a measure
for viremia in domestic cats and is consistently found in
domestic cats with a progressive FeLV infection outcome
[26, 28]. Additionally, blood, buffy coat, serum and tissue
samples from both jaguarundis were positive for FeLV
proviral DNA and viral RNA with high proviral and viral
loads, respectively (Table 4). While the presence of proviral
DNA attests to the integration of provirus into blood cells,
the detection of viral RNA usually indicates replicating
virus. Once the infection outcome has been established,
high proviral and FeLV RNA loads are characteristically
found in cats with progressive infection, while low loads are
detected in cats with regressive infection that are provirus
positive but not viremic at the time [25, 29, 50]. FeLV
proviral and viral RNA loads were measured in the two
FeLV-positive jaguarundis #1 and #4. Comparison of the
FeLV tissue loads of jaguarundi #1 revealed loads similar to
those reported earlier for domestic cats with progressive
infection using identical methods. Viral RNA loads in
serum from the two FeLV-positive jaguarundis were com-
parable to those described earlier in persistently antigene-
mic cats [30]. The viral RNA load in the clinically healthy
jaguarundi #1 was slightly lower than that in jaguarundi #4,
which showed weight loss, vomiting, anorexia and diarrhea
before death. This is also similar to previous findings from
a study in cats, comparing viremic healthy and viremic ill
cats [51]. Moreover, consistent with findings in domestic
cats with a progressive FeLV infection, no antibodies to
FeLV antigens were detected in jaguarundis #1 and #4.
FeLV RNA and FeLV provirus were also detected in
the saliva of jaguarundi #1. This finding is indicative of
virus shedding; thus, jaguarundi #1 was a potential
source of FeLV infection to other felids. Jaguarundi #1
was euthanized in good clinical condition as a biosafety
measure. However, upon necropsy, histopathologic
evaluation revealed splenic lymphoid depletion and
muscular atrophy of the hind limbs; these findings may
be associated with immunosuppression and neurological
impairment in this animal. Jaguarundi #4 died present-
ing weight loss and gastrointestinal disorders including
vomiting, anorexia and diarrhea. Histopathology
revealed splenic alterations and evidence of enteritis
(Table 3). Although these conditions are commonly
associated with FeLV in domestic cats, it was not
possible to ascertain whether they were caused by FeLV
infection in this case.
Two captive-born jaguarundis, #2 and #22, presented
test results similar to those reported for domestic cats
with abortive FeLV infection and seroconversion as the
only marker of FeLV exposure [28]. The female jaguarundi
#2 had a history of direct contact with the two jaguarundis
with progressive FeLV infection, #1 and #4: she was a
sibling of jaguarundi #1 and had mated with the male #4.
Table 4 Feline leukemia virus (FeLV) viral and proviral loads from jaguarundis (Puma yagouaroundi) presenting putative progressive
infection
Animal Viral load (RNA) by RT-qPCR Proviral load (DNA) by qPCR
Seruma Salivab Mesenteric
lymph nodec
Bone
marrowc
Spleenc Buffy
coata
Salivab Mesenteric
lymph nodec
Bone
marrowc
Spleenc
#1 2.63 × 108 1.65 × 105 1.31 × 100 4.74 × 100 1.74 × 100 4.26 × 107 1.88 × 103 2.64 × 10−1 5.61 × 10−1 3.68 × 10−1
#4 2.97 × 109 Ntd Nt Nt Nt 3.49 x 107 Nt Nt Nt Nt
aTotal copy numbers of FeLV RNA or provirus detected per mL of serum or buffy coat, respectively. bTotal copy numbers detected per reaction (5 μL of total
nucleic acid – TNA); no absolute quantification was possible since the input saliva volume from the swab sample was not known. cTotal copy numbers detected
per reaction in tissue samples, normalized to the copy number of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene. dNt not tested; samples were
not available
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Fig. 1 Analysis of the evolutionary relationship using the maximum parsimony (MP) method with 20 sequences. a Relationships at the DNA level. Tree #1
out of the 2 most parsimonious trees (length = 1616) is shown. The consistency index is (0.622642), the retention index is (0.696970), and the composite
index is 0.515827 (0.433962) for all sites and parsimony-informative sites (in parentheses). There were a total of 1837 positions in the final dataset. b
Relationships at the protein level. The most parsimonious tree, with length = 637, is shown. The consistency index is (0.750000), the retention index is
(0.747664), and the composite index is 0.620901 (0.560748) for all sites and parsimony-informative sites (in parentheses). There were a total of 605 positions
in the final dataset. The percentages of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 replicates) are shown next
to the branches. The tree is drawn to scale, with the length being relative to the number of changes over the entire sequence. The MP tree was obtained
using the subtree-pruning-regrafting (SPR) algorithm with search level 1 in which the initial trees were obtained by the random addition of sequences (10
replicates). All positions containing gaps and missing data were eliminated. Analyses were conducted in MEGA 6 [44–47, 63]
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This would explain how she was exposed to FeLV, either
at the same time as her sibling #1 or during mating with
#4. Subsequently, jaguarundi #2 gave birth to jaguarundi
#23, who did not show any signs of FeLV exposure (Ta-
bles 1, 2, 4). This may well be the case, since the mother,
#2, had developed an antibody response and probably had
never shed FeLV (abortive infection). It is unknown for
how long and at what virus challenge conditions jaguarundi
#2 was exposed, as animals were naturally and not experi-
mentally infected in the present study. Overall, we speculate
that jaguarundi #2 developed an abortive FeLV infection for
similar (and possibly several) reasons that may drive FeLV
abortive infections in some domestic cats. The parents of
male jaguarundi #22 were the FeLV-negative male jaguar-
undi #5 and the female #7. Thus, it is unknown at what
time point jaguarundi #22 was exposed to FeLV.
Overall, we provide evidence of progressive and abort-
ive FeLV infection in P. yagouaroundi. Similar results
have been found in Florida panthers (Puma concolor
coryi), which belong to the felid lineage 6 (genus Puma),
the same phylogenetic lineage as the jaguarundis [52]. In
Florida panthers, infection outcomes resembled those of
domestic cats with progressive, regressive and abortive
infection (previously persistent, regressive, and latent
infection) [20, 21]. We speculate that FeLV infection in
jaguarundis is similarly unpredictable, and it is influ-
enced for the same diverse aspects cited above for
domestic cats.
Complimentary to the fact that FeLV causes various tu-
mors in domestic cats [53], the literature has reported a
FeLV-associated multicentric T-cell lymphoma in a captive
non-domestic cheetah (Acinonyx jubatus) [54] and non-
FeLV-associated T- and B-cell lymphomas in geriatric
African lions (Panthera leo) [55]. These data motivated
the search for possible FeLV involvement in the appear-
ance of the neoplastic intra-abdominal mass in jaguarundi
#5. Although jaguarundi #5 had not shown any evidence
of FeLV infection intra vitam (Table 1), we further investi-
gated whether FeLV antigens or proviruses were present
in intestinal lymphoid cells and whether these cells pro-
duced FeLV viral RNA locally without it entering the
bloodstream – as would be expected in a case of seques-
tered FeLV infection [4]. However, no FeLV antigens were
detected by immunohistochemistry and no FeLV provirus
or viral RNA were detected by molecular assays. Infection
with FIV, which is a lentivirus associated with lymphoma-
genesis in domestic cats [56], was not detected by the
commercial immunoassay, and only antibodies specific to
FIV p24 capsid proteins were detected by Western blot,
which may be indicative of an early or very late FIV infec-
tion or may have resulted from unspecific cross-reactivity.
The FIV RT-PCR assays performed from whole blood
were negative; however, this may be due to low viral loads
or lack of specificity of the assays due to sequence
diversity of different FIV isolates. In conclusion, jaguar-
undi #5 had developed a non FeLV-associated intestinal
B-cell lymphoma; involvement of FIV in the development
of the neoplasia cannot completely be ruled out.
Notably, a spleen sample from jaguarundi #5 had been
previously analyzed for the presence of the FeLV receptor
fTHTR1, which permits the virus to enter the cell. The
fTHTR1 complementary DNA (cDNA) from that animal
had shown 99% nucleotide and amino acid identity to the
fTHTR1 cDNA sequences of the domestic cat and other
wild felid species, such as the lynx (Lynx pardinus),
African lion (P. leo bleyenberghi), Asiatic lion (P. leo
persica), and European wildcat (F. silvestris silvestris) [57].
In addition, fTHTR1 was quantified by real-time PCR in a
few tissues from two jaguarundis where tissue was avail-
able (the viremic jaguarundi #1 and jaguarundi #5, which
developed a tumor, but was not FeLV-infected).These lim-
ited results showed no significant difference between the
fTHTR1 tissue loads in cat and jaguarundi tissue (results
not shown). However, it also needs to be mentioned that
the real-time PCR assay was designed for the domestic cat
THTR1 and not the jaguarundi THTR1. Two-point muta-
tions can be found in the region of the assay: one-point
mutation in the middle of the forward primer and one in
the probe. Thus, although similar fTHTR1 expression
levels were found in jaguarundi tissue compared with cat
tissue, we cannot exclude differences in the efficiency of
the real-time PCR assay. These findings support the per-
spective that the first phase of the FeLV virus cycle – viral
entry – might be similar among domestic cats and other
wild felid species.
We did not detect enFeLV in the jaguarundis by qPCR.
This is consistent with earlier data [58] in which enFeLV
was not detected in jaguarundis. Accordingly, FeLV-B,
which has greater pathogenicity than FeLV-A in domes-
tic cats and arises by recombination of exogenous FeLV-
A with enFeLV sequences [59], was not found in the two
FeLV-positive jaguarundis #1 and #4. Moreover, the
highly virulent FeLV-C was not detected. In FeLV-
infected Iberian lynxes, enFeLV sequences were also not
detected, but their FeLV-A variants were shown to be
highly virulent, suggesting that the mechanisms inducing
disease in these wild felids might be distinct from those
in domestic cats [19].
The env sequence obtained from the FeLV infections
of jaguarundis #1 and #4 [KR349469] clustered with the
highest identity with the FeLV-FAIDS and FeLV-3281
strains, which represent members of a highly conserved
group of horizontally transmitted, minimally pathogenic
FeLV-A present in all naturally occurring infections in
domestic cats. Both FeLV strains were originally isolated
from cats in the United States of America (USA) [60,
61]. Interestingly, the surface unit of the env sequence of
FeLV detected in the jaguarundis also showed 97%
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identity to those of the env gene of FeLV isolated from
the critically endangered Iberian lynxes [EU293175 to
EU293194] in Spain, whose small wild population suf-
fered from an outbreak of FeLV with several deaths [18].
Both PCR-positive jaguarundis, #1 and #4, were infected
with a FeLV with an identical env sequence, indicating a
common origin of the virus. It is unknown at what time
point each of the jaguarundis became infected. The repro-
ductive success achieved for jaguarundis in captivity is
probably a result of the breeding program conceived for
small felids at FPZSP [62] and a number of measures for
improving the well-being of the animals, including the loca-
tion of the jaguarundi enclosures in an isolated and forested
area of the zoo away from the public. Nonetheless, domes-
tic cats commonly are seen invading the zoo, especially the
more isolated areas, and they were probably the source of
infection of FeLV for the jaguarundis. Domestic cats are the
main reservoir for FeLV worldwide and greatly outnumber
FeLV-infected wild felids. Given this, it is prudent to pre-
vent the presence of domestic cats in nature reserves, zoos
and other settings with captive wild felids and to reinforce
the importance of control measures for FeLV in domestic
cats, such as testing and vaccination.
A severe FeLV outbreak occurred in a previously naïve
population of Florida panthers (Puma concolor coryi) in
North America from 2002 to 2005 in which five FeLV
antigen-positive panthers died [20, 21]. During a six-month
period in 2007, six provirus-positive antigenemic Iberian
lynxes (Lynx pardinus) died in Spain [18, 19]. In both situa-
tions, FeLV vaccination programs were initiated. We
recommend safe recombinant subunits or inactivated FeLV
vaccines for captive jaguarundis, especially considering that
invading domestic cats, potential sources of infection, are a
frequent problem faced by zoos. In addition, we recom-
mend the inclusion of FeLV testing in breeding programs
for jaguarundis.
Conclusions
Our findings support our hypothesis that FeLV infection
in P. yagouaroundi mimics the outcomes observed for
the domestic cat. In addition, we found phylogenetic evi-
dence that domestic cats may have been the source of
the FeLV-A infection of the jaguarundis. Despite the
minimal pathogenicity of FeLV-A for domestic cats, this
virus may represent a threat to the jaguarundi popula-
tion, and regular FeLV testing and vaccination are
encouraged.
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